DAY vs REGN · P/E 345, rev $1.76B vs P/E 14, rev $14.34B
Dayforce Inc. (DAY) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Dayforce Inc. (DAY) is a software - application company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported DAY revenue for 2024-12-31 was $1.76B. Net income was $18.1M. Revenue was up 16.3% from 2023-12-31 to 2024-12-31. DAY currently screens at market cap $8.81B and trailing P/E 344.5.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
DAY currently screens at market cap $8.81B and trailing P/E 344.5. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the DAY and REGN stock pages for the full models.
Not investment advice.